ObvioHealth, founded with a mission to revolutionize clinical trials through digital solutions, offers a comprehensive platform that supports both observational and interventional studies. Their core vision is to enhance the efficiency and accuracy of clinical trials by integrating smart devices and real-time interactions. The company's services include decentralized trials, recruitment and screening, remote patient monitoring, and patient engagement, primarily targeting markets in the United States and Singapore.
Notable affiliates and investors include healthcare industry leaders and technology innovators who support ObvioHealth's pioneering approach. The company has achieved significant milestones, such as developing the ObvioGo platform, which streamlines electronic patient-reported outcomes (ePRO) and eConsent processes. ObvioHealth's impact is evident in its ability to facilitate more efficient, patient-centric clinical trials, thereby accelerating the development of new treatments and therapies.
